Clinical Trial Update: Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer [NA]

View source ↗

Summary

Rutgers is recruiting for a clinical study to investigate metabolic pathways in hormone receptor-positive/HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Breast Cancer | NA | Status: RECRUITING